Animate Biosciences Highlights Preclinical Results Showing Marked Improvement in Heart Function Post-Heart Attack
Animate Biosciences Reports Preclinical Data Showing Dramatic Reduction in Cardiac Scarring and Near-Doubling of Heart Function After Experimental Heart Attack Animate Biosciences, a biotechnology company focused on designing innovative peptide therapeutics, today announces positive preclinical results demonstrating that its lead…
PureTech Secures Orphan Drug Designations in U.S. and EU for Deupirfenidone (LYT-100) in IPF
PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis PureTech Health plc a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value,…
Atrandi Biosciences Expands SPC Innovator Kit Line to Advance Single-Cell Multiomics
Atrandi Biosciences Redefines Single-Cell Multiomics with Expanded SPC Innovator Kit Portfolio Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today announced the launch of its new 170 µm and 300 µm SPC Innovator Kits, the company’s most versatile SPC…
GekkoVet and Royal Canin Debut in Mexico, Extending Partnership into Latin America
GekkoVet and Royal Canin Enter Latin America with Mexico Launch, Opening a New Continent in their Global Partnership GekkoVet, the Finnish leader in AI-powered clinical decision support for veterinarians, and Royal Canin, a global pioneer in pet health through nutrition,…
bit.bio Expands Global Access to Human Cells with New Pricing and Hub
bit.bio Accelerates Global Access to Human Cells with New Pricing Model and Distribution Hub Following a record Q4 in sales volume and the successful closing of $50 million in new funding, bit.bio is leveraging its economies of scale to substantially…
ImmunityBio Expands EU Access to ANKTIVA® with New Distribution Deal
ImmunityBio Expands Access to ANKTIVA® in EU with New Distribution Partnership and Opens Irish Subsidiary to Support European Launch ImmunityBio, Inc. a commercial-stage immunotherapy company, today announced a partnership with Accord Healthcare to provide access to ANKTIVA® (nogapendekin alfa inbakicept) in combination…
Doc.com Launches in Florida to Broaden U.S. Expansion of AI-Driven Healthcare Platform
Doc.com Expands U.S. Rollout with Florida Launch, Advancing AI-Powered Blockchain Secured Healthcare Access Doc.com, the pioneering healthcare technology company redefining access to care through artificial intelligence and blockchain integration, today announced the launch of its telemedicine platform in Florida as…
SullivanCotter Names Devin Paullin Senior VP of Strategic Business Partners
SullivanCotter Welcomes Devin Paullin as Senior Vice President of Strategic Business Partners SullivanCotter, the nation’s leading independent consulting firm in the assessment and development of total rewards programs, workforce solutions, and data products for health care and not-for-profits, is pleased…
athenahealth Introduces Agentic Patient Engagement Solutions Across Nationwide Provider Network
athenahealth Launches Agentic Patient Communication Tools Across Its Provider Network, Which Serves One in Five Americans athenahealth today announced the next generation of its AI-native patient engagement suite within athenaOne ®, designed to simplify how patients and practices communicate. The…
Unified Women’s Healthcare Addresses Growing Demand for Menopause Care
Unified Women’s Healthcare Responds to Rising Demand for Menopause Care Unified Women’s Healthcare (Unified), in partnership with its OBGYN affiliates, is expanding access to perimenopause and menopause care nationwide through Unified for You, its patient resource platform and corresponding awareness campaign, which…
Case Study Shows CyPath® Lung Reduces Diagnostic Burden in At-Risk Patients
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer bioAffinity Technologies, Inc. a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a new…
NexEos Bio Secures FDA Green Light to Progress NTX-1024 into Phase II/III Clinical Development
NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis NexEos Bio Vision Health a clinical-stage biopharmaceutical company developing novel therapies and diagnostics targeting eosinophil-mediated diseases, today announced that the U.S.…